Tech Company Financing Transactions
Exosome Diagnostics Funding Round
Exosome Diagnostics secured a $17.6 million Series B funding round on 9/4/2015. Investors included Arcus Ventures, CD Ventures and Forbion Capital Partners.
Transaction Overview
Company Name
Announced On
9/4/2015
Transaction Type
Venture Equity
Amount
$17,600,000
Round
Series B
Investors
Proceeds Purpose
These funds also will enable us to drive our next generation of cancer diagnostics and, importantly, begin expanding into other disease areas, potentially bringing the benefits of exosome-based molecular diagnostics to patients across a broad spectrum of indications and medical needs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
266 Second Ave. 200
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Developing and commercializing personalized biofluid-based diagnostic tests for use in companion diagnostic applications and real-time disease monitoring.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Boyce
Chief Financial Officer
William Kelly
Chief Medical Officer
Vincent O'Neill
Chief Operating Officer
Thomas McLain
Chief Scientific Officer
Johan Skog
VP - Product Management
Mikkel Noerholm
VP - Regulatory Affairs
Raaj Venkatesan
Browse more venture capital transactions:
Prev: 9/4/2015: GoToTags venture capital transaction
Next: 9/4/2015: OMsignal venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs